May 28, 2026 Anaveon Reports Clinical Benefit of ANV600 in the EXPAND-1 Phase 1 Clinical Trial at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio
May 28, 2026 XL‑protein Launches Spin-Off PASylANTA Therapeutics to Develop Long‑Acting IL‑1Ra Biobetters
May 28, 2026 Stellar Alpina Raises CHF 3.5M to Build Detonation-Based Propulsion for Mobility After Launch
